Conference Reports for NATAP
HIV Glasgow 2026
8-11 November
Back
 
Tweet
Immunogenicity and associated safety of amtabafusp alfa, a bispecific T-cell engager, in a phase 1b study in people with HIV
Glasgow 2026 Nov 8-11
Princy Kumar, MD